![Qiang Lü](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Qiang Lü
Director/Miembro de la Junta en GOODY SCIENCE AND TECHNOLOGY CO., LTD. .
Cargos activos de Qiang Lü
Empresas | Cargo | Inicio | Fin |
---|---|---|---|
GOODY SCIENCE AND TECHNOLOGY CO., LTD. | Director/Miembro de la Junta | 28/12/2020 | - |
Genfleet Therapeutics (Shanghai), Inc.
![]() Genfleet Therapeutics (Shanghai), Inc. Miscellaneous Commercial ServicesCommercial Services Genfleet Therapeutics (Shanghai), Inc. is a Chinese clinical-stage biotechnology company that focuses on developing novel drug candidates for unmet medical needs in oncology and immunology. The company is based in Shanghai, China, and was founded in 2017 by Jiong Lan and Qiang Lü. The company has built up industry-leading capabilities and expertise in developing both small molecules and biologics since its inception in 2017. Genfleet's proprietary and fully integrated R&D platform highlights multiple cutting-edge products with novel mechanisms and IP. The company's pipeline includes over 10 programs, many of which have entered multi-regional clinical trials across China. Genfleet has completed co-development partnerships with a number of publicly listed companies worldwide. Jiong Lan has been the CEO since 2017. | Presidente | 22/08/2017 | - |
Fundador | 22/08/2017 | - |
Historial de carrera de Qiang Lü
Estadísticas
Internacional
China | 3 |
Operativa
Director/Board Member | 1 |
Chairman | 1 |
Founder | 1 |
Sectorial
Producer Manufacturing | 2 |
Commercial Services | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
GOODY SCIENCE AND TECHNOLOGY CO., LTD. | Producer Manufacturing |
Empresas privadas | 1 |
---|---|
Genfleet Therapeutics (Shanghai), Inc.
![]() Genfleet Therapeutics (Shanghai), Inc. Miscellaneous Commercial ServicesCommercial Services Genfleet Therapeutics (Shanghai), Inc. is a Chinese clinical-stage biotechnology company that focuses on developing novel drug candidates for unmet medical needs in oncology and immunology. The company is based in Shanghai, China, and was founded in 2017 by Jiong Lan and Qiang Lü. The company has built up industry-leading capabilities and expertise in developing both small molecules and biologics since its inception in 2017. Genfleet's proprietary and fully integrated R&D platform highlights multiple cutting-edge products with novel mechanisms and IP. The company's pipeline includes over 10 programs, many of which have entered multi-regional clinical trials across China. Genfleet has completed co-development partnerships with a number of publicly listed companies worldwide. Jiong Lan has been the CEO since 2017. | Commercial Services |
- Bolsa de valores
- Insiders
- Qiang Lü
- Experiencia